
Northwestern Medicine Lake Forest Hospital uses dual chamber pacemaker implant to aid patient
Jerry Karzen has had many successes as both a tennis player and a coach. Now he is getting the chance to extend those accomplishments with the assistance of a new generation of pacemaker.
In January, Karzen was one of the first patients to receive a new dual chamber leadless (pronounced LEED-less) pacemaker now offered at Northwestern Medicine Lake Forest Hospital. The device received Food and Drug Administration approval in 2023 and went into use inside the Northwestern medical system last summer.
For Karzen, 71, his journey toward implantation occurred two to three years ago when he noticed his endurance decrease.
'I was getting tired much quicker than I thought I should,' Karzen remembered.
It was a frustrating development for Karzen, a professional tennis player in the 1970s who competed at the sport's major tournaments, including Wimbledon and the U.S. Open. He later won United States Tennis Academy-sanctioned championships with his children and has coached the New Trier girls' tennis team to state titles. Plus, he operates his own tennis club in Glenview.
Frustrated with the lack of stamina, Karzen took a series of tests, but they all proved inconclusive. Then, about nine months ago, Karzen underwent a cardiopulmonary stress test that revealed a lower heart rate during intense exercise. He was only reaching 96 beats a minute, when it should have been between 120-130.
Karzen discussed the situation initially with his primary care physician and soon they connected with his friend and fellow tennis player, Dr. Nishant Verma, an electrophysiologist at Lake Forest Hospital.
Verma believed Karzen would be a candidate for the new pacemaker that is about the size of a Triple A battery.
'His main problem was his upper chamber not allowing his heart rate to go fast enough,' he said. 'This leadless device can sit in the upper chamber and increase that. Prior leadless devices did not have that capability.'
Verma said one main difference of this pacemaker is that it is inserted through a small incision in the leg and not the arm. He added that in a traditional pacemaker, there is a battery under the skin and then there are wires that connect to that battery. The wires are connected through a vein under the collarbone that leads into the heart and plug it into the battery that is sitting in the chest.
In this case, there aren't any wires left behind.
'That is a significant advancement because those wires can have issues over time including fracture or they can infected,' he said. 'Also, if they have been in for an extended period of time, removing them is quite challenging and has significant risks.'
Verma said these pacemakers are only implanted on the upper and lower right side of the heart chamber.
'This is the first time we have a leadless system that functions exactly the same as a traditional pacemaker, with one unit in the upper chamber of the heart and one unit in the lower chamber, and they are able to communicate with one another.'
He added, 'That mimics your natural electrical system because the electrical signal comes from the right upper chamber and goes to the right lower chamber. The two devices are what is quite unique about this. It is pretty slick.'
Another advancement is a much faster recovery time for patients. In traditional pacemakers, a patient can't carry any more than 10 pounds in the left arm and can't lift the left elbow over the shoulder for about six weeks.
With Karzen still playing and coaching tennis, a lengthy recovery would have been an issue.
'For you as an athlete this would be a better option and it never existed before,' Verma recalled telling Karzen.
Verma presented the information to Karzen, who acknowledged having some caution due to the lack of time the new pacemaker has been widely available. But he decided to move forward, becoming one of the first to do so at Lake Forest Hospital.
'There is trepidation but eventually you have confidence in the doctors and the people who are doing the procedures,' he said.
In January, Verma inserted the pacemaker into Karzen during an operation that typically lasts two to three hours.
Karzen was back on the tennis court about a week and his recovery continues with his heart rate returning to normal levels.
'I feel like things are better, but there is still a distance to go,' he said. 'It wasn't a magic bullet and I am not 30 again, but it will give me the chance to last longer.'
Verma said the dual-chamber pacemakers might not be right for every patient as it depends on the type of heart issue someone faces. In addition, given its recent debut on the market, safety data is still being collected, and it is yet to be determined how long the device will last.
Yet overall he remains pleased with the initial results in Karzen and his other patients.
Karzen echoes that sentiment hoping he has charted a new recovery path for people facing heart issues.
'I hope it can help me,' Karzen said. 'And I hope it can help others.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Kennedy names 8 vaccine committee replacements, including COVID shot critic
NEW YORK (AP) — U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week. They include a scientist who researched mRNA vaccine technology and transformed into a conservative darling for his criticisms of COVID-19 vaccines, and a leading critic of pandemic-era lockdowns. Kennedy's decision to 'retire' the previous 17-member panel was widely decried by doctors' groups and public health organizations, who feared the advisers would be replaced by a group aligned with Kennedy's desire to reassess — and possibly end — longstanding vaccination recommendations. The new appointees to the Advisory Committee on Immunization Practices include Dr. Robert Malone, the former mRNA researcher who emerged as a close adviser to Kennedy during the measles outbreak. Malone, who runs a wellness institute and a popular blog, rose to popularity during the COVID-19 pandemic as he relayed conspiracy theories around the outbreak and the vaccines that followed. He has appeared on podcasts and other conservative news outlets where he's promoted unproven and alternative treatments for measles and COVID-19. He has claimed that millions of Americans were hypnotized into taking the COVID-19 shots. He's even suggested that those vaccines cause a form of AIDS. He's downplayed deaths related to one of the largest measles outbreaks in the U.S. in years. Other appointees include Dr. Martin Kulldorff, a biostatistician and epidemiologist who was a co-author of the Great Barrington Declaration, an October 2020 letter maintaining that pandemic shutdowns were causing irreparable harm. Dr. Cody Meissner, a former ACIP member, also was named. Kennedy made the announcement in a social media post on Wednesday. The committee, created in 1964, makes recommendations to the director of the Centers for Disease Control and Prevention. CDC directors almost always approve those recommendations on how Food and Drug Administration-cleared vaccines should be used. The CDC's final recommendations are widely heeded by doctors and determine the scope of vaccination programs. ___ Associated Press reporter Amanda Seitz contributed to this report. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.


The Hill
2 hours ago
- The Hill
Lawmakers urge Trump administration to clamp down on illicit GLP-1 sales
A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing these drugs without knowing the product could be fraudulent. North Carolina Reps. Brad Knott (R) and Deborah Ross (D) wrote to Food and Drug Administration (FDA) Commissioner Marty Makary, Homeland Security Secretary Kristi Noem and U.S. Attorney General Pam Bondi, imploring them to end the sale of 'counterfeit, research-grade and illegal copycats' of popular GLP-1 medications. When the commercial, branded versions of tirzepatide and semaglutide were declared to no longer be in shortage, compounding pharmacies were disallowed from continuing to sell compounded versions of those drugs. While telehealth companies have transitioned away from compounded versions, state officials have warned that 'copycat' drugs have proliferated in the months since the shortages ended. Earlier this year, the National Association of Attorneys General sent a letter to the FDA to warn that 'counterfeit GLP-1 drugs have infiltrated the U.S. supply chain from China, Turkey, India, and other foreign sources.' According to the attorneys general, online retailers sell the active ingredient for the GLP-1s under the claim that they're 'for research purposes only' or 'not for human consumption' while still marketing them to consumers on social media. The FDA issued a warning in April, telling consumers to not take counterfeit Ozempic. The drug's manufacturer, Novo Nordisk, had alerted the agency that several hundred units of counterfeit product had entered the U.S. supply chain. At the time, the FDA said it was aware of six adverse events associated with the counterfeit products. Though the FBI issued a public service warning soon after the letter from the attorneys general was sent, Knott and Ross said raising public awareness wasn't enough. 'FDA has received hundreds of reports of adverse events, even some resulting in the hospitalization and death of patients who used illicit GLP-1s,' they wrote. 'This is likely a significant underreporting of adverse events experienced by patients because federal law does not require state-licensed pharmacies that are not outsourcing facilities to submit adverse events to FDA.' The lawmakers asked that the Trump Cabinet members fully use 'the legal tools at your discretion' to further detect illicit and enforce U.S. drug standards. Sen. Thom Tillis (R-N.C.) sent his own letter to Cabinet members, calling for enhanced collaboration among agencies like FDA, U.S. Customs and Border Protection and the Justice Department in order to stop the counterfeit products from reaching the supply chain in the first place. The Hill has reached out to the agencies named in the letter for comment.


NBC Sports
4 hours ago
- NBC Sports
Women's tennis adds ranking protection for fertility procedures such as egg or embryo freezing
ST. PETERSBURG, Fla. — Professional tennis players who take time off from competition for a fertility procedure such as egg or embryo freezing will have their ranking protected under a WTA Tour policy announced Wednesday. This follows the introduction in March of paid maternity leave and grants for fertility protection measures in women's tennis. Under the new protected ranking rule covering absences for fertility procedures, players can use the special ranking to enter up to three tournaments. Players already were eligible for ranking protection while pregnant or other ways of becoming a parent. 'For any woman, the conversation of family life versus a career is nuanced and complex,' 2017 U.S. Open champion Sloane Stephens said in a statement released by the tour. 'The WTA has now created a safe space for players to explore options and to make the best decisions for themselves.'